NCT00074841View on ClinicalTrials.gov

Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

January 31, 2005

Conditions
PLASMODIUM FALCIPARUM MALARIA
Interventions
DRUG

Azithromycin/Chloroquine

DRUG

Sulfadoxine-Pyrimethamine/Chloroquine

Trial Locations (7)

400012

Pfizer Investigational Site, Parel Mumbai

403002

Pfizer Investigational Site, Bambolim

452001

Pfizer Investigational Site, Indore

769005

Pfizer Investigational Site, Rourkela

781006

Pfizer Investigational Site, Dispur Guwahati

440 018

Pfizer Investigational Site, Nagpur

632 004

Pfizer Investigational Site, Vellore

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY